CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Raltitrexed

雷替曲塞 杂质对照品Raltitrexed Impurities

46 个杂质条目46 impurity entries

本页汇总 雷替曲塞 的 46 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 46 impurity reference standards of Raltitrexed. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 雷替曲塞(Raltitrexed)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsChiral separation of raltitrexed by cyclodextrin-modified micellar electrokinetic chromatography
    Analytical and bioanalytical chemistry · 2009 · Liu Y et al.  ·  PMID 18931995  ·  DOI
  2. 分析方法Analytical MethodsDetermination of raltitrexed in human plasma by high performance liquid chromatography-electrospray ionization-mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2007 · Hu J et al.  ·  PMID 17459788  ·  DOI
  3. 分析方法Analytical MethodsA simple and fast LC-MS/MS method with a very high sensitivity for the measurement of raltitrexed in human plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2017 · Kim S et al.  ·  PMID 28628839  ·  DOI

雷替曲塞 —— 原料药与杂质对照品Raltitrexed — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Raltitrexed structure
原料药 APIAPI
雷替曲塞Raltitrexed
Raltitrexed
CAS No.112887-68-0
Chemical FormulaC21H22N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 1 structure
1
雷替曲塞杂质1Raltitrexed Impurity 1
Raltitrexed Impurity 1
CAS No.112888-43-4
Chemical FormulaC10H9BrN2O
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 2 structure
2
雷替曲塞杂质2Raltitrexed Impurity 2
Raltitrexed Impurity 2
CAS No.112889-02-8
Chemical FormulaC15H22N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 3 structure
3
雷替曲塞杂质3Raltitrexed Impurity 3
Raltitrexed Impurity 3
CAS No.39978-57-9
Chemical FormulaC5H2ClNO3S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 4 structure
4
雷替曲塞杂质4Raltitrexed Impurity 4
Raltitrexed Impurity 4
CAS No.132463-02-6
Chemical FormulaC25H30N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 5 structure
5
雷替曲塞杂质5Raltitrexed Impurity 5
Raltitrexed Impurity 5
CAS No.106585-64-2
Chemical FormulaC14H18N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 6 structure
6
雷替曲塞杂质6Raltitrexed Impurity 6
Raltitrexed Impurity 6
CAS No.651295-44-2
Chemical FormulaC19H28N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 7 structure
7
雷替曲塞杂质7Raltitrexed Impurity 7
Raltitrexed Impurity 7
CAS No.132463-32-2
Chemical FormulaC10H15NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 8 structure
8
雷替曲塞杂质8Raltitrexed Impurity 8
Raltitrexed Impurity 8
CAS No.131052-68-1
Chemical FormulaC11H15NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 9 structure
9
雷替曲塞杂质9Raltitrexed Impurity 9
Raltitrexed Impurity 9
CAS No.4282-31-9
Chemical FormulaC6H4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 10 structure
10
雷替曲塞杂质10Raltitrexed Impurity 10
Raltitrexed Impurity 10
CAS No.132463-33-3
Chemical FormulaC20H30N2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 11 structure
11
雷替曲塞杂质11Raltitrexed Impurity 11
Raltitrexed Impurity 11
CAS No.651295-42-0
Chemical FormulaC15H19NO7S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 12 structure
12
雷替曲塞杂质12Raltitrexed Impurity 12
Raltitrexed Impurity 12
CAS No.64624-37-9
Chemical FormulaC10H12N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 13 structure
13
雷替曲塞杂质13Raltitrexed Impurity 13
Raltitrexed Impurity 13
CAS No.2165318-81-8
Chemical FormulaC11H14N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 14 structure
14
雷替曲塞杂质14Raltitrexed Impurity 14
Raltitrexed Impurity 14
CAS No.2180168-65-2
Chemical FormulaC11H14N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 15 structure
15
雷替曲塞杂质15Raltitrexed Impurity 15
Raltitrexed Impurity 15
CAS No.2180168-66-3
Chemical FormulaC12H16N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 16 structure
16
雷替曲塞杂质16Raltitrexed Impurity 16
Raltitrexed Impurity 16
CAS No.1378372-01-0
Chemical FormulaC10H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 17 structure
17
雷替曲塞杂质17Raltitrexed Impurity 17
Raltitrexed Impurity 17
CAS No.6317-37-9
Chemical FormulaC5H3NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 18 structure
18
雷替曲塞杂质18Raltitrexed Impurity 18
Raltitrexed Impurity 18
CAS No.132462-57-8
Chemical FormulaC20H20N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 20 structure
20
雷替曲塞杂质20Raltitrexed Impurity 20
Raltitrexed Impurity 20
CAS No.1042419-89-5
Chemical FormulaC21H22N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 21(Proquinazid) structure
21
雷替曲塞杂质21(丙氧喹啉)Raltitrexed Impurity 21(Proquinazid)
Raltitrexed Impurity 21(Proquinazid)
CAS No.189278-12-4
Chemical FormulaC14H17IN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 22 structure
22
雷替曲塞杂质22Raltitrexed Impurity 22
Raltitrexed Impurity 22
CAS No.1825377-03-4
Chemical FormulaC21H22N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 23 structure
23
雷替曲塞杂质23Raltitrexed Impurity 23
Raltitrexed Impurity 23
CAS No.138899-70-4
Chemical FormulaC15H15N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 25 structure
25
雷替曲塞杂质25Raltitrexed Impurity 25
Raltitrexed Impurity 25
CAS No.1379347-57-5
Chemical FormulaC10H9ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 27 structure
27
雷替曲塞杂质27Raltitrexed Impurity 27
Raltitrexed Impurity 27
CAS No.1802925-55-8
Chemical FormulaC10H8N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 28 structure
28
雷替曲塞杂质28Raltitrexed Impurity 28
Raltitrexed Impurity 28
CAS No.3025735-36-5
Chemical FormulaC23H26N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 31 structure
31
雷替曲塞杂质31Raltitrexed Impurity 31
Raltitrexed Impurity 31
CAS No.666853-39-0
Chemical FormulaC11H15NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 32 structure
32
雷替曲塞杂质32Raltitrexed Impurity 32
Raltitrexed Impurity 32
CAS No.1094071-11-0
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 35 structure
35
雷替曲塞杂质35Raltitrexed Impurity 35
Raltitrexed Impurity 35
CAS No.1235852-48-8
Chemical FormulaC11H13N3O
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 36 structure
36
雷替曲塞杂质36Raltitrexed Impurity 36
Raltitrexed Impurity 36
CAS No.138899-69-1
Chemical FormulaC16H15N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 37 structure
37
雷替曲塞杂质37Raltitrexed Impurity 37
Raltitrexed Impurity 37
CAS No.2135790-65-5
Chemical FormulaC21H20N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 38 structure
38
雷替曲塞杂质38Raltitrexed Impurity 38
Raltitrexed Impurity 38
CAS No.2190532-75-1
Chemical FormulaC21H22N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 40 structure
40
雷替曲塞杂质40Raltitrexed Impurity 40
Raltitrexed Impurity 40
CAS No.292068-69-0
Chemical FormulaC10H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 41 structure
41
雷替曲塞杂质41Raltitrexed Impurity 41
Raltitrexed Impurity 41
CAS No.2300115-52-8
Chemical FormulaC11H15NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 42 structure
42
雷替曲塞杂质42Raltitrexed Impurity 42
Raltitrexed Impurity 42
CAS No.3027529-13-8
Chemical FormulaC13H19NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 47 structure
47
雷替曲塞杂质47Raltitrexed Impurity 47
Raltitrexed Impurity 47
CAS No.859915-41-6
Chemical FormulaC7H9NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 48 structure
48
雷替曲塞杂质48Raltitrexed Impurity 48
Raltitrexed Impurity 48
CAS No.859915-40-5
Chemical FormulaC6H7NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 49 structure
49
雷替曲塞杂质49Raltitrexed Impurity 49
Raltitrexed Impurity 49
CAS No.1065107-02-9
Chemical FormulaC7H9NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 53 structure
53
雷替曲塞杂质53Raltitrexed Impurity 53
Raltitrexed Impurity 53
CAS No.2308589-02-6
Chemical FormulaC10H9BrN2O
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 55 structure
55
雷替曲塞杂质55Raltitrexed Impurity 55
Raltitrexed Impurity 55
CAS No.2918997-66-5
Chemical FormulaC10H8Br2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 58 structure
58
雷替曲塞杂质58Raltitrexed Impurity 58
Raltitrexed Impurity 58
CAS No.18731-19-6
Chemical FormulaC10H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 59 structure
59
雷替曲塞杂质59Raltitrexed Impurity 59
Raltitrexed Impurity 59
CAS No.2383114-92-7
Chemical FormulaC10H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 60 structure
60
雷替曲塞杂质60Raltitrexed Impurity 60
Raltitrexed Impurity 60
CAS No.67081-68-9
Chemical FormulaC10H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 61 structure
61
雷替曲塞杂质61Raltitrexed Impurity 61
Raltitrexed Impurity 61
CAS No.3113-72-2
Chemical FormulaC8H7NO4
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 66 structure
66
雷替曲塞杂质66Raltitrexed Impurity 66
Raltitrexed Impurity 66
CAS No.857759-75-2
Chemical FormulaC10H8N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 68 structure
68
雷替曲塞杂质68Raltitrexed Impurity 68
Raltitrexed Impurity 68
CAS No.1174316-17-6
Chemical FormulaC12H17NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Raltitrexed Impurity 69 structure
69
雷替曲塞杂质69Raltitrexed Impurity 69
Raltitrexed Impurity 69
CAS No.481710-98-9
Chemical FormulaC12H12N2O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

雷替曲塞 —— 研究文献与合成路线Raltitrexed — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 雷替曲塞 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Raltitrexed. Titles link to the original records; copyright remains with the authors and publishers.

合成与制备工艺专利Synthesis & process patents

  1. Improved process of preparing Raltitrexed
    XIUHUA WEI · 公开号 CN101088997CN101088997 · 2007
  2. Inclusion containing raltitrexed and preparation
    GAO YONGLIANG, WANG DONGXING, WU XIAOYU, YUN LIUHONG · 公开号 CN1682726CN1682726 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

雷替曲塞 杂质谱研究要点Raltitrexed — impurity profiling notes

下面这些是拿到 雷替曲塞 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Raltitrexed, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances